Original Publication Date: 1 August, 2014
Publication / Source: International Journal of Hematologic Oncology
Authors: Leonard T Heffner Jr
Over the last seven decades, Waldenström macroglobulinemia (WM) has changed from a clinical observation by an astute clinician to an uncommon, but well-defined clinical–pathologic entity. Similarly, therapeutic advances have evolved and now parallel our increasing understanding of the biology of WM.